Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02384226 · ClinicalTrials.gov registry record
User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study
A clinical trial of Preeclampsia and Gestational Hypertension, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 26
- Enrollment target
- 1
- Study location
NCT02384226 is a study of Preeclampsia and Gestational Hypertension that has completed, run by University of Colorado, Denver. The registered enrollment target is 26 participants, below the 1,281-participant average among 39 other Preeclampsia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02384226, a study of Preeclampsia and Gestational Hypertension, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
Refine content and delivery of the mHealth delivered lifestyle intervention program through iterative testing with small groups of users who provide feedback through on-line asynchronous focus groups.
Conditions Studied
Study Locations (1)
Colorado
- University of Colorado Hospital - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2015-09 |
| Est. Completion | 2020-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02384226
The ClinicalTrials.gov registry entry for NCT02384226 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,281-participant average among 39 other Preeclampsia trials with a reported enrollment target (98% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Preeclampsia appearing as the primary indexed condition, and to 0 interventions.
NCT02384226 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT02384226 about?
NCT02384226 is a clinical study titled "User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study". Refine content and delivery of the mHealth delivered lifestyle intervention program through iterative testing with small groups of users who provide feedback through on-line asynchronous focus groups.
What is the current status of trial NCT02384226?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2015-09. Estimated completion is 2020-09.
What conditions does trial NCT02384226 study?
This clinical trial studies the following conditions: Preeclampsia, Gestational Hypertension, Gestational Diabetes Mellitus, Pre-term Delivery, Delivery of Small for Gestational Age (SGA) Baby.
Who is sponsoring clinical trial NCT02384226?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02384226 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
RECRUITING · Phase 2
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Daily Aspirin Treatment After Preeclampsia
RECRUITING · Early Phase 1
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
Exosome Cargo From Preeclampsia Patients
RECRUITING
-
Prenatal Aspirin and Postpartum Vascular Function
RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.